- Home
- DECK vs DGX Comparison
DECK vs DGX Comparison
Compare DECK & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DECK
- DGX
- Stock Information
- Founded
- DECK 1973
- DGX 1967
- Country
- DECK United States
- DGX United States
- Employees
- DECK N/A
- DGX N/A
- Industry
- DECK Shoe Manufacturing
- DGX Medical Specialities
- Sector
- DECK Consumer Discretionary
- DGX Health Care
- Exchange
- DECK Nasdaq
- DGX Nasdaq
- Market Cap
- DECK 16.6B
- DGX 19.2B
- IPO Year
- DECK 1993
- DGX 1996
- Fundamental
- Price
- DECK $125.63
- DGX $175.90
- Analyst Decision
- DECK Buy
- DGX Buy
- Analyst Count
- DECK 19
- DGX 14
- Target Price
- DECK $189.63
- DGX $185.07
- AVG Volume (30 Days)
- DECK 2.3M
- DGX 1.4M
- Earning Date
- DECK 05-22-2025
- DGX 04-22-2025
- Dividend Yield
- DECK N/A
- DGX 1.82%
- EPS Growth
- DECK 33.68
- DGX 6.41
- EPS
- DECK 6.15
- DGX 7.91
- Revenue
- DECK $4,923,590,000.00
- DGX $10,158,000,000.00
- Revenue This Year
- DECK $18.15
- DGX $10.28
- Revenue Next Year
- DECK $10.42
- DGX $4.05
- P/E Ratio
- DECK $20.44
- DGX $22.24
- Revenue Growth
- DECK 19.52
- DGX 9.38
- 52 Week Low
- DECK $93.72
- DGX $135.47
- 52 Week High
- DECK $223.98
- DGX $179.32
- Technical
- Relative Strength Index (RSI)
- DECK 64.07
- DGX 57.57
- Support Level
- DECK $115.10
- DGX $175.25
- Resistance Level
- DECK $120.58
- DGX $179.32
- Average True Range (ATR)
- DECK 3.76
- DGX 3.80
- MACD
- DECK 2.64
- DGX 0.30
- Stochastic Oscillator
- DECK 92.54
- DGX 82.28
About DECK Deckers Outdoor Corporation
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2024, Ugg and Hoka accounted for 52% and 42% of total sales, respectively. The firm also markets niche brands Teva and Ahnu. Deckers produces most of its sales through wholesale partnerships, but also operates e-commerce in more than 50 countries and about 178 company-operated stores. It generated 67% of its fiscal 2024 sales in the United States.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.